Theratechnologies Acquires Targeted Oncology Company Katana Biopharma Inc. Feb 25, 2019 PDF Version Supporting Materials: Theratechnologies Acquires Targeted Oncology Company Katana Biopharma Inc. 254.2 KB Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce the acquisition of Katana Biopharma Inc. (Katana) and its targeted oncology technology platform.